These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17142081)

  • 1. Molecular pathogenesis of severe acute respiratory syndrome.
    Wang H; Rao S; Jiang C
    Microbes Infect; 2007 Jan; 9(1):119-26. PubMed ID: 17142081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-associated coronavirus.
    Holmes KV
    N Engl J Med; 2003 May; 348(20):1948-51. PubMed ID: 12748314
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.
    Weiss SR; Navas-Martin S
    Microbiol Mol Biol Rev; 2005 Dec; 69(4):635-64. PubMed ID: 16339739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS: understanding the virus and development of rational therapy.
    Stadler K; Rappuoli R
    Curr Mol Med; 2005 Nov; 5(7):677-97. PubMed ID: 16305493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular entry of the SARS coronavirus.
    Hofmann H; Pöhlmann S
    Trends Microbiol; 2004 Oct; 12(10):466-72. PubMed ID: 15381196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic mechanisms of severe acute respiratory syndrome.
    Guo Y; Korteweg C; McNutt MA; Gu J
    Virus Res; 2008 Apr; 133(1):4-12. PubMed ID: 17825937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aetiology: Koch's postulates fulfilled for SARS virus.
    Fouchier RA; Kuiken T; Schutten M; van Amerongen G; van Doornum GJ; van den Hoogen BG; Peiris M; Lim W; Stöhr K; Osterhaus AD
    Nature; 2003 May; 423(6937):240. PubMed ID: 12748632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS--beginning to understand a new virus.
    Stadler K; Masignani V; Eickmann M; Becker S; Abrignani S; Klenk HD; Rappuoli R
    Nat Rev Microbiol; 2003 Dec; 1(3):209-18. PubMed ID: 15035025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development.
    Navas-Martín SR; Weiss S
    J Neurovirol; 2004 Apr; 10(2):75-85. PubMed ID: 15204926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus.
    Feng Y; Gao GF
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):309-27. PubMed ID: 17640731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS coronavirus: a new challenge for prevention and therapy.
    Holmes KV
    J Clin Invest; 2003 Jun; 111(11):1605-9. PubMed ID: 12782660
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.
    Frieman M; Yount B; Agnihothram S; Page C; Donaldson E; Roberts A; Vogel L; Woodruff B; Scorpio D; Subbarao K; Baric RS
    J Virol; 2012 Jan; 86(2):884-97. PubMed ID: 22072787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Basis of Coronavirus Virulence and Vaccine Development.
    Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
    Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Chow KY; Hon CC; Hui RK; Wong RT; Yip CW; Zeng F; Leung FC
    Genomics Proteomics Bioinformatics; 2003 Nov; 1(4):247-62. PubMed ID: 15629054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
    Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
    J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine design for severe acute respiratory syndrome coronavirus.
    He Y; Jiang S
    Viral Immunol; 2005; 18(2):327-32. PubMed ID: 16035944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
    Venkataraman T; Coleman CM; Frieman MB
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.
    See RH; Petric M; Lawrence DJ; Mok CPY; Rowe T; Zitzow LA; Karunakaran KP; Voss TG; Brunham RC; Gauldie J; Finlay BB; Roper RL
    J Gen Virol; 2008 Sep; 89(Pt 9):2136-2146. PubMed ID: 18753223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS.
    Yip MS; Leung HL; Li PH; Cheung CY; Dutry I; Li D; Daëron M; Bruzzone R; Peiris JS; Jaume M
    Hong Kong Med J; 2016 Jun; 22(3 Suppl 4):25-31. PubMed ID: 27390007
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.
    Lin JT; Zhang JS; Su N; Xu JG; Wang N; Chen JT; Chen X; Liu YX; Gao H; Jia YP; Liu Y; Sun RH; Wang X; Yu DZ; Hai R; Gao Q; Ning Y; Wang HX; Li MC; Kan B; Dong GM; An Q; Wang YQ; Han J; Qin C; Yin WD; Dongs XP
    Antivir Ther; 2007; 12(7):1107-13. PubMed ID: 18018769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.